EyePoint Pharmaceuticals
EYPT
EYPT
41 hedge funds and large institutions have $33M invested in EyePoint Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
44% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 18
Holders
41
Holding in Top 10
–
Calls
$735K
Puts
$45K
Top Buyers
| 1 | +$6.03M | |
| 2 | +$1.6M | |
| 3 | +$787K | |
| 4 |
DM
Deerfield Management
New York
|
+$726K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$496K |
Top Sellers
| 1 | -$591K | |
| 2 | -$366K | |
| 3 | -$228K | |
| 4 |
SIM
Spark Investment Management
New York
|
-$183K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$174K |